Covered recipient · General Payments record
LAURA M MACY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$918.59
- Reported across 45 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $476.07 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $157.50 | 12 |
| Novo Nordisk AS | $62.93 | 3 |
| Acerta Pharma LLC | $44.30 | 2 |
| Astellas Pharma US Inc | $40.13 | 2 |
| Amgen Inc. | $33.56 | 2 |
| Exact Sciences Corporation | $32.34 | 2 |
| Antares Pharma, Inc. | $31.20 | 2 |
| Axsome Therapeutics, Inc. | $23.43 | 1 |
| PFIZER INC. | $22.05 | 1 |
| Abbott Laboratories | $14.67 | 1 |
| Lundbeck LLC | $13.96 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $14.67 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125144547 | CMS |
| ABBVIE INC. | $18.75 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103759846 | CMS |
| ABBVIE INC. | $13.55 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103759848 | CMS |
| ABBVIE INC. | $6.76 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103759850 | CMS |
| ABBVIE INC. | $16.47 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103759852 | CMS |
| ABBVIE INC. | $11.14 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103759854 | CMS |
| ABBVIE INC. | $13.96 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103759856 | CMS |
| ABBVIE INC. | $11.34 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103759858 | CMS |
| ABBVIE INC. | $10.65 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103759860 | CMS |
| ABBVIE INC. | $16.10 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103759862 | CMS |
| ABBVIE INC. | $15.13 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103759864 | CMS |
| ABBVIE INC. | $9.45 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103759866 | CMS |
| ABBVIE INC. | $14.20 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103759868 | CMS |
| Amgen Inc. | $15.95 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111640068 | CMS |
| Amgen Inc. | $17.61 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111640070 | CMS |
| Antares Pharma, Inc. | $14.78 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146459072 | CMS |
| Antares Pharma, Inc. | $16.42 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146459076 | CMS |
| Astellas Pharma US Inc | $19.04 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139328234 | CMS |
| Astellas Pharma US Inc | $21.09 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139367931 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.48 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104772186 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.82 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105225934 | CMS |
| Axsome Therapeutics, Inc. | $23.43 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148298064 | CMS |
| Exact Sciences Corporation | $17.78 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114517450 | CMS |
| Exact Sciences Corporation | $14.56 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114517454 | CMS |
| Lundbeck LLC | $13.96 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145916791 | CMS |
| Novo Nordisk Inc | $15.44 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096886779 | CMS |
| Novo Nordisk Inc | $23.78 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096684270 | CMS |
| Novo Nordisk Inc | $23.71 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097415704 | CMS |
| PFIZER INC. | $22.05 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131209178 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.